Drugs / LBVE01
last change Jul 2019 re-read 2 minutes ago

LBVE01

Developed for
pneumococcal infection
Investigated by
LG Chem

Trials 1 · a red edge is where a trial was stopped

20192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT03549208 Jul 2018 → Apr 2019 pneumococcal infection LG Chem Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as LBVE01 ClinicalTrials.gov intervention name — accepted as the source's own label NCT03549208